Colorectal cancer (CRC) is the second most prevalent cause of cancer-related mortality and is increasing in younger individuals.
Chemotherapy, a crucial adjuvant systemic therapy for CRC management, often leads to resistance through poorly characterized underlying molecular mechanisms.
The long noncoding RNA
